KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Inventory (2017 - 2025)

Historic Inventory for Dynavax Technologies (DVAX) over the last 9 years, with Q3 2025 value amounting to $73.3 million.

  • Dynavax Technologies' Inventory rose 1744.5% to $73.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $73.3 million, marking a year-over-year increase of 1744.5%. This contributed to the annual value of $70.1 million for FY2024, which is 3145.81% up from last year.
  • Per Dynavax Technologies' latest filing, its Inventory stood at $73.3 million for Q3 2025, which was up 1744.5% from $75.7 million recorded in Q2 2025.
  • Dynavax Technologies' Inventory's 5-year high stood at $102.6 million during Q3 2022, with a 5-year trough of $49.4 million in Q3 2023.
  • Moreover, its 5-year median value for Inventory was $67.3 million (2021), whereas its average is $68.0 million.
  • Its Inventory has fluctuated over the past 5 years, first surged by 5894.07% in 2021, then plummeted by 5184.44% in 2023.
  • Dynavax Technologies' Inventory (Quarter) stood at $61.3 million in 2021, then fell by 3.08% to $59.4 million in 2022, then dropped by 10.36% to $53.3 million in 2023, then soared by 31.46% to $70.1 million in 2024, then increased by 4.62% to $73.3 million in 2025.
  • Its Inventory was $73.3 million in Q3 2025, compared to $75.7 million in Q2 2025 and $74.4 million in Q1 2025.